Exposed Groups | WBC (×109/L) | RBC (×1012/L) | PLATELET (×109/L) | PCV (%) | HB (g/dL) |
Control | 4.15 ± 0.74d | 3.09 ± 0.38d | 195 ± 0.48a | 36.75 ± 0.70b | 13.15 ± 0.08a |
Group 1a | 5.75 ± 0.78abc | 3.6 ± 0.28ab | 254.0 ± 2.83a | 36.0 ± 2.83b | 12.83 ± 0.25c |
Group 1b | 5.0 ± 0.28a | 3.95 ± 0.35abc | 258.5 ± 2.12b | 40.5 ± 0.71c | 15.29 ± 0.86d |
Group 1c | 5.45 ± 1.34ab | 4.9 ± 0.42c | 254.5 ± 0.71b | 47.0 ± 1.41d | 16.22 ± 0.17e |
Group 1d | 6.65 ± 0.71bcd | 4.95 ± 1.06c | 248.5 ± 2.12d | 48.5 ± 0.71d | 15.12 ± 0.17d |
Group 2a | 7.55 ± 0.49de | 4.60 ± 0.28bc | 232.0 ± 2.82c | 46.0 ± 0.00d | 15.74 ± 0.09de |
Group 2b | 5.8 ± 0.28abc | 3.4 ± 0.28a | 219.50 ± 2.83d | 47.0 ± 1.41d | 15.51 ± 0.14d |
Group 2c | 7.55 ± 0.49de | 3.6 ± 0.28ab | 211.50 ± 6.36d | 35.0 ± 1.41ab | 11.32 ± 0.03ab |
Group 2d | 8.25 ± 0.21e | 3.25 ± 0.35a | 222.0 ± 2.82b | 35.0 ± 1.41ab | 11.72 ± 0.04b |
Group 2e | 7.15 ± 0.63cd | 3.9 ± 0.14abc | 202.5 ± 2.12ab | 32.5 ± 0.71a | 10.93 ± 0.04a |